4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001754067-26-000002
Chief Technology Officer sold 3,147 shares at $1.96 ($6,168)
- Chief Technology Officer acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kelly Timothy P · Chief Technology Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-20 | Grant or award : show line 1 in the form | +45,000 | 82,500 | D | ||
| 2026-02-24 | Sale : show line 2 in the form | −3,147 | $1.96 | $6,168 | 79,353 | D |
| Open-market sales · 3,147 sh · avg $1.96 · $6,168 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-20 | Grant or award : show line 3 in the form Option to purchase Common Stock | +202,500 | 202,500 | D |
Loading xslF345X05/wk-form4_1771984478.xml…